Del Rincón-Loza I

No ORCID on file · 1 paper in corpus · active 2021
2021
Frontiers in immunology ·doi:10.3389/fimmu.2021.717850

Adoptive cellular immunotherapy using chimeric antigen receptor (CAR)-modified T cells and Natural Killer (NK) cells are common immune cell sources administered to treat cancer patients. In detail, whereas CAR-T cells induce outstanding res…